BNP Paribas Discount Zert MRNA 30.../ DE000PN7LP64 /
2024-08-05 9:40:14 PM | Chg.-1.000 | Bid9:59:47 PM | Ask9:59:47 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
56.970EUR | -1.73% | 57.090 Bid Size: 1,000 |
57.190 Ask Size: 1,000 |
Moderna Inc | - USD | 2024-12-30 | Call |
GlobeNewswire
06-13
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - ...
GlobeNewswire
06-05
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - ...
GlobeNewswire
05-22
Oruka Therapeutics Expands Leadership Team with Appointment of Industry Veterans Drs. Joseph Senn an...
GlobeNewswire
05-12
TrialWire Patient Recruitment Platform that Reboots Stalled Clinical Trials announced as Multi-Award...
GlobeNewswire
05-08
CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
05-08
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Bi...
GlobeNewswire
05-02
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
05-01
Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems